Healthcare provider profile · identity verified

Assefa Worku, MD

Internal Medicine · SAN JOSE, CA · NPI 1003127986

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	421	145
Amlodipine Besylate	Amlodipine Besylate	319	106
Lisinopril	Lisinopril	220	69
Fluticasone Propionate	Fluticasone Propionate	148	70
Levothyroxine Sodium	Levothyroxine Sodium	136	46
Metformin Hcl	Metformin Hcl	129	46
Metoprolol Tartrate	Metoprolol Tartrate	127	42
Albuterol Sulfate Hfa	Albuterol Sulfate	124	56
Atenolol	Atenolol	115	37
Simvastatin	Simvastatin	114	39
Tamsulosin Hcl	Tamsulosin Hcl	109	40
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	108	40
Omeprazole	Omeprazole	100	35
Losartan Potassium	Losartan Potassium	99	43
Terazosin Hcl	Terazosin Hcl	96	29
Gabapentin	Gabapentin	89	39
Famotidine	Famotidine	80	29
Hydrochlorothiazide	Hydrochlorothiazide	72	26
Metoprolol Succinate	Metoprolol Succinate	71	30
Allopurinol	Allopurinol	62	22
Alvesco	Ciclesonide	48	26
Trazodone Hcl	Trazodone Hcl	48	14
Ibuprofen	Ibuprofen	47	25
Wixela Inhub	Fluticasone Propion/Salmeterol	46	19
Glipizide	Glipizide	45	19
Metformin Hcl Er	Metformin Hcl	45	17
Hydralazine Hcl	Hydralazine Hcl	41	17
Furosemide	Furosemide	40	16
Jardiance	Empagliflozin	34	15
Triamcinolone Acetonide	Triamcinolone Acetonide	34	18
Spiriva Respimat	Tiotropium Bromide	33	14
Tizanidine Hcl	Tizanidine Hcl	33	16
Alendronate Sodium	Alendronate Sodium	32	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	suppressed
Potassium Chloride	Potassium Chloride	32	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	31	12
Hydrocortisone	Hydrocortisone	27	15
Nortriptyline Hcl	Nortriptyline Hcl	27	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	27	suppressed
Prednisone	Prednisone	27	20
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Lovastatin	Lovastatin	26	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	23	23
Clopidogrel	Clopidogrel Bisulfate	23	suppressed
Tadalafil	Tadalafil	23	suppressed
Sertraline Hcl	Sertraline Hcl	22	suppressed
Meloxicam	Meloxicam	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	21	suppressed
Finasteride	Finasteride	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Baclofen	Baclofen	19	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Montelukast Sodium	Montelukast Sodium	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Azithromycin	Azithromycin	18	15
Fluocinonide	Fluocinonide	18	suppressed
Naproxen	Naproxen	18	suppressed
Rizatriptan	Rizatriptan Benzoate	18	suppressed
Clonazepam	Clonazepam	17	suppressed
Raloxifene Hcl	Raloxifene Hcl	17	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	15	suppressed
Carvedilol	Carvedilol	15	suppressed
Cefadroxil	Cefadroxil	14	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	13
Warfarin Sodium	Warfarin Sodium	14	suppressed
Zenpep	Lipase/Protease/Amylase	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Nabumetone	Nabumetone	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	13	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Humulin N	Insulin Nph Human Isophane	12	suppressed
Ozempic	Semaglutide	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error